X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16530) 16530
Newsletter (4181) 4181
Book Review (1515) 1515
Publication (936) 936
Conference Proceeding (127) 127
Magazine Article (120) 120
Newspaper Article (119) 119
Dissertation (45) 45
Trade Publication Article (32) 32
Book Chapter (29) 29
Paper (7) 7
Web Resource (3) 3
Book / eBook (1) 1
Reference (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
simvastatin (16113) 16113
index medicus (11281) 11281
humans (9171) 9171
male (6312) 6312
female (5087) 5087
statins (4701) 4701
middle aged (4094) 4094
antilipemic agents (3521) 3521
cholesterol (3479) 3479
research (3472) 3472
animals (3147) 3147
aged (3073) 3073
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (2916) 2916
simvastatin - therapeutic use (2826) 2826
pharmacology & pharmacy (2700) 2700
simvastatin - pharmacology (2497) 2497
adult (2459) 2459
atorvastatin (2425) 2425
cardiac & cardiovascular systems (2130) 2130
hypercholesterolemia (2055) 2055
pravastatin (2048) 2048
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (1960) 1960
anticholesteremic agents - therapeutic use (1805) 1805
drugs (1785) 1785
reports (1760) 1760
risk factors (1683) 1683
abridged index medicus (1677) 1677
treatment outcome (1661) 1661
analysis (1594) 1594
rats (1594) 1594
lovastatin (1534) 1534
simvastatin - administration & dosage (1524) 1524
hypercholesterolemia - drug therapy (1522) 1522
cholesterol, ldl - blood (1505) 1505
atherosclerosis (1454) 1454
care and treatment (1424) 1424
atorvastatin calcium (1338) 1338
medicine, general & internal (1321) 1321
drug therapy (1306) 1306
lipids (1305) 1305
universities and colleges (1244) 1244
peripheral vascular disease (1218) 1218
prevention (1211) 1211
risk (1208) 1208
medical research (1202) 1202
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (1171) 1171
coronary-heart-disease (1143) 1143
cholesterol - blood (1122) 1122
therapy (1119) 1119
drug therapy, combination (1075) 1075
low density lipoproteins (1075) 1075
mice (1072) 1072
medicine, experimental (1041) 1041
ezetimibe (1011) 1011
cardiovascular agents (1009) 1009
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (988) 988
inflammation (984) 984
dose-response relationship, drug (975) 975
statin (970) 970
disease (912) 912
lovastatin - analogs & derivatives (884) 884
cardiovascular disease (869) 869
health aspects (865) 865
apoptosis (852) 852
simvastatin - adverse effects (843) 843
coa reductase inhibitors (839) 839
expression (838) 838
time factors (836) 836
double-blind method (832) 832
hypolipidemic agents - therapeutic use (826) 826
dosage and administration (825) 825
coronary heart disease (804) 804
mortality (790) 790
heptanoic acids - therapeutic use (782) 782
diabetes (779) 779
pyrroles - therapeutic use (771) 771
lipids - blood (770) 770
cardiovascular diseases (765) 765
triglycerides - blood (745) 745
efficacy (740) 740
biochemistry & molecular biology (730) 730
myocardial-infarction (721) 721
physiological aspects (712) 712
cells, cultured (711) 711
endocrinology & metabolism (706) 706
lovastatin - therapeutic use (696) 696
anticholesteremic agents - administration & dosage (685) 685
hypercholesterolemia - blood (679) 679
anticholesteremic agents - pharmacology (675) 675
medicine, research & experimental (674) 674
aged, 80 and over (673) 673
safety (665) 665
rosuvastatin (664) 664
c-reactive protein (662) 662
clinical trials (662) 662
in-vitro (658) 658
drug interactions (637) 637
cholesterol, hdl - blood (636) 636
hyperlipidemias - drug therapy (636) 636
cardiovascular (629) 629
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19932) 19932
German (179) 179
Chinese (165) 165
Russian (144) 144
Spanish (132) 132
French (117) 117
Portuguese (68) 68
Italian (65) 65
Korean (43) 43
Japanese (42) 42
Polish (39) 39
Swedish (35) 35
Czech (20) 20
Danish (19) 19
Hungarian (15) 15
Dutch (14) 14
Norwegian (14) 14
Turkish (13) 13
Persian (4) 4
Croatian (3) 3
Finnish (3) 3
Arabic (2) 2
Romanian (2) 2
Catalan (1) 1
Hebrew (1) 1
Malay (1) 1
Serbian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pharmaceutical Research, ISSN 0724-8741, 6/2015, Volume 32, Issue 6, pp. 1864 - 1883
To develop a population physiologically-based pharmacokinetic (PBPK) model for simvastatin (SV) and its active metabolite, simvastatin acid (SVA), that allows... 
Biochemistry, general | Biomedical Engineering | drug-drug interactions | Biomedicine | Pharmacy | PBPK | simvastatin | Medical Law | population model | Pharmacology/Toxicology | OATP1B1 | HYDROXY ACID | VARIANTS | DRUG-INTERACTIONS | "simvastatin" | QUANTIFICATION | IN-VITRO DATA | "population model" | "OATP1B1" | STATINS | CHEMISTRY, MULTIDISCIPLINARY | DISPOSITION | PRIOR DISTRIBUTIONS | "PBPK" | PHARMACOLOGY & PHARMACY | "drug-drug interactions" | PRAVASTATIN | INHIBITORS | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Activation, Metabolic | Cytochrome P-450 Enzyme Inhibitors - therapeutic use | Simvastatin - adverse effects | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - blood | Biological Availability | Muscle, Skeletal - metabolism | Hydroxymethylglutaryl-CoA Reductase Inhibitors - chemistry | Healthy Volunteers | Simvastatin - blood | Organic Anion Transporters - metabolism | Tissue Distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Organic Anion Transporters - genetics | Drug Interactions | Liver - drug effects | Muscle, Skeletal - drug effects | Muscular Diseases - chemically induced | Pharmacogenetics | Reproducibility of Results | Simvastatin - chemistry | Muscular Diseases - metabolism | Simvastatin - administration & dosage | Liver - metabolism | Simvastatin - pharmacokinetics | Simvastatin - analogs & derivatives | Polymorphism, Genetic | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Models, Biological | Solute Carrier Organic Anion Transporter Family Member 1b1 | Metabolites | Simvastatin | Drug interactions | Liver | Cytochrome P-450 | Antilipemic agents | Side effects | Pharmacology | Kinetics | Statins | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 16, pp. C174 - C175
Journal Article
Pharmacogenetics and Genomics, ISSN 1744-6872, 12/2006, Volume 16, Issue 12, pp. 873 - 879
Journal Article
JAMA DERMATOLOGY, ISSN 2168-6068, 06/2018, Volume 154, Issue 6, pp. 725 - 726
Journal Article
Journal Article
Experimental Eye Research, ISSN 0014-4835, 03/2007, Volume 84, Issue 3, p. 464
Proliferative vitreoretinopathy (PVR) is a major cause of the failure of rhegmatogenous retinal detachment surgery. The pathogenesis of PVR includes a fibrotic... 
Simvastatin
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 01/2007, Volume 9, Issue 1, p. 30
Simvastatin can prevent cardiac remodelling after myocardial infarction, though the exact mechanisms are uncertain. Myocardial no-reflow is associated with... 
Simvastatin
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 10/2014, Volume 96, Issue 4, pp. 423 - 428
Journal Article
Journal Article
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 3/2015, Volume 71, Issue 3, pp. 341 - 355
Systemic exposure to rosuvastatin is approximately double that of Caucasians in Asian subjects. We investigated whether this pattern of increased exposure... 
SLCO1B1 | Pharmacogenetics | Biomedicine | Caucasian | Pharmacology/Toxicology | Pharmacokinetics | Asian | ABCG2 | WHITE | ADULT MALE-VOLUNTEERS | RISK | OATP1B1 | DISPOSITION | MARKEDLY AFFECTS | TRANSPORT | SYSTEMIC EXPOSURE | DISEASE | PHARMACOLOGY & PHARMACY | HEALTHY-VOLUNTEERS | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Simvastatin - adverse effects | Atorvastatin Calcium - blood | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - blood | Middle Aged | Rosuvastatin Calcium - adverse effects | Asian Continental Ancestry Group - genetics | Male | Simvastatin - blood | Young Adult | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Organic Anion Transporters - genetics | ATP-Binding Cassette Transporters - genetics | Adult | Female | Neoplasm Proteins - genetics | Rosuvastatin Calcium - blood | Atorvastatin Calcium - adverse effects | Atorvastatin Calcium - pharmacokinetics | European Continental Ancestry Group - genetics | Rosuvastatin Calcium - pharmacokinetics | Genotype | Simvastatin - pharmacokinetics | Simvastatin - analogs & derivatives | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Adolescent | Polymorphism, Single Nucleotide - genetics | Aged | Solute Carrier Organic Anion Transporter Family Member 1b1 | Genetic aspects | Rosuvastatin | Simvastatin | Antilipemic agents | Genotype & phenotype | Whites | Pharmacology | Statins | Asians | Polymorphism | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Liver | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article